December 29, 2008 - A combination treatment of prostate cancer can cut death rates in half, according to results from a Scandinavian study published in the Dec. 16 online issue of The Lancet.

December 29, 2008 – When Zemiva, an imaging agent by Molecular Insight Pharmaceuticals Inc., is combined with the standard of care for the diagnostic evaluation of the chest pain patient, improved the detection of cardiac ischemia by more than 50 percent greater than the standard of care when compared to the standard of care alone.

December 29, 2008 - Accuray Inc. said that 100 CyberKnife Robotic Radiosurgery Systems now have been installed within the U.S.

This milestone was achieved with the installation of a CyberKnife System at Brandon Regional Hospital in Brandon, FL.

December 23, 2008 - The risk of developing lymphedema is 40 percent to 60 percent higher in women with body mass index (BMI) classified as overweight or obese compared to normal weight women, according to a new study by researchers at the University of Missouri (MU).

December 23, 2008 - Amgen has submitted a Biologics License Application (BLA) with the FDA for denosumab, an investigational RANK Ligand inhibitor, as Amgen seeks FDA approval for treatment and prevention of postmenopausal osteoporosis (PMO) in women, and treatment and prevention of bone loss in patients undergoing hormone ablation for either prostate or breast cancer.

December 23, 2008 - The FDA cleared Ion Beam Applications’ (IBA) cyclotron-based integrated commercial proton therapy system with pencil beam scanning (PBS), a delivery method that allows for precise dose delivery by its proton therapy system.

December 23, 2008 - The Moscow Municipal University of Psychology and Education in Moscow, Russia, and the University of Trento in Trento, Italy, have ordered Elekta Neuromag, equipment for noninvasive measurement of brain activity using magnetoencephalography (MEG) technology, for research purposes.

December 23, 2008 – The Cross Cancer Institute (CCI) in Edmonton, Alberta, Canada reported today that medical physicists have produced the first image from a linac-MR hybrid system on Dec. 10, 2008.

December 23, 2008 — The Alfred in Melbourne, Australia, used AngioDynamics’s NanoKnife system, which leverages irreversible electroporation (IRE) technology, on a lymph node metastasis and the first lung lesion case.

December 23, 2008 – The FDA approved for marketing EPIX Pharmaceuticals’ novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now